MWC 2025: Amdocs Opens GenAI-Focused Experience Lab in North America, Showcasing Leading-Edge Generative AI Capabilities that Fuel Business Growth

JERSEY CITY, NJ – February 28, 2025 - Amdocs (NASDAQ: DOX), a leading provider of software and services to communications and media companies, today announced the expansion and evolution of the Amdocs Experience Lab, its cutting-edge innovation facility located in Dallas, Texas. The new lab emerges with a larger physical footprint, AI-centric hardware and infrastructure, and an evolved focus on generative AI (GenAI), serving as an innovation catalyst for emerging GenAI capabilities.

As one of the first telecom-focused labs to showcase production-proven GenAI capabilities, the Amdocs Experience Lab draws on the Amdocs group's R&D innovation centers in Israel and India and brings together the entire suite of Amdocs’ AI and GenAI products and services to showcase tangible, scalable GenAI-powered experiences that span the entire telco lifecycle, from infrastructure to customer care. Additionally, the lab serves as the home of Amdocs’ Open GenAI Lab Incubator, where enterprises, startups and partners alike are able to trial new capabilities in a cohort model, leveraging the best of Amdocs and advanced partner technology in one place. As generative AI evolves to agentic AI, collaboration environments such as our Experience Lab will be the place to create future AI agents for telecom networks.

According to a recent study [1], improving customer experience and increasing operating efficiency are two of the top three business priorities for service providers globally. GenAI is uniquely positioned to address both of these imperatives, and visitors to the Amdocs Experience Lab will see firsthand how customers are achieving meaningful results toward this goal. This includes a recent customer trial of the Amdocs amAIz-powered care agent that led to dramatic improvements in the experience of their customers by, for example, improving average handling time (AHT) by nearly 63%.

Visitors can experience the latest GenAI advancements powered by Amdocs amAIz and Amdocs’ rich ecosystem of GenAI partners. These advancements include:

• Customer care, sales and technical support digital humans, built using NVIDIA NeMo and Amazon SageMaker
• Enterprise ordering and operations optimization, featuring Microsoft Azure OpenAI Service
• Customer interaction & agent assistance, featuring Google’s Customer Engagement Suite
• Network digital twin and operations, built with the NVIDIA Omniverse platform
• AI Factory including Amdocs amAIz, Marketplace & Monetization for NVIDIA accelerated computing platforms and AI services, powered by Dell Technologies’ Servers (w/ GPUs) and Infrastructure Automation Suite
• ORAN network automation & pre-staging, based on NVIDIA NIM microservices

“The Amdocs Experience Lab is a physical manifestation of our commitment to technology-enabled innovation, and a reflection of the reality that GenAI is fundamentally changing the way we live and work,” said Anthony Goonetilleke, Group President of Technology and Head of Strategy at Amdocs. “We’ve built a collaborative space that not only highlights the transformative power of our GenAI platforms but also brings to life how Amdocs and our partners are driving new possibilities for our customers in an increasingly AI-first world, while taking advantage of Dallas’ important role in global technology innovation.”

1 OMDIA’s IT Enterprise Insights: Telecom 2025 Report

Supporting Resources

• Learn more about Amdocs Experience Lab
• Keep up with Amdocs news by visiting the company’s website
• Follow us on X, Facebook, LinkedIn and YouTube

About Amdocs

Amdocs helps those who build the future to make it amazing. With our market-leading portfolio of software products and services, we unlock our customers' innovative potential, empowering them to provide next-generation communication and media experiences for both the individual end user and large enterprise customers. Our employees around the globe are here to accelerate service providers' migration to the cloud, enable them to differentiate in the 5G era, and digitalize and automate their operations. Listed on the NASDAQ Global Select Market, Amdocs had revenue of $5.00 billion in fiscal 2024.

Amdocs’ Forward-Looking Statement

This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs’ growth and business results in future quarters and years. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general macro-economic conditions, prevailing level of macroeconomic, business and operational uncertainty, including as a result of geopolitical events or other global or regional events or pandemics, as well as the current inflationary environment, and the effects of these conditions on the company’s customers’ businesses and levels of business activity, including the effect of the current economic uncertainty and industry pressure on the spending decisions of the company’s customers, Amdocs’ ability to grow in the business markets that it serves, Amdocs’ ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company’s products and services obsolete, security incidents, including breaches and cyberattacks to our systems and networks and those of our partners or customers potential loss of a major customer, our ability to develop long-term relationships with our customers, our ability to successfully and effectively implement artificial intelligence and Generative AI in the company’s  offerings and operations and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, Amdocs specifically disclaims any obligation to do so. These and other risks are discussed at greater length in Amdocs’ filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2024 filed on December 17, 2024 and our Form 6-K furnished for the first quarter of fiscal 2025 on February 18, 2025.

Media Contacts

Michael Zema
Amdocs Public Relations
mzema@amdocs.com

Emily Holt
PAN Communications for Amdocs
amdocs@pancomm.com